FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:51-53 July 3, 1997 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Diuguid, D. L. Related Article by Schulman, S. Related Article by Schulman, S. PubMed Citation

To the Editor: Schulman et al. (Feb. 6 issue)¹ reported that long-term anticoagulant therapy may benefit patients with recurrent venous thromboembolism. Their conclusions will be difficult to interpret in a clinical setting, however, because of the heterogeneity of their study population. Twenty percent of their patients were identified as having temporary risk factors for thromboembolism. For them, removing or resolving the risk factor may substantially reduce the risk of recurrent thrombosis, independently of the anticoagulant therapy; moreover, intuitively, those patients would be expected to be the best candidates for a short course of such therapy. The failure either to exclude . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.